Paris Panayiotopoulos
Founder bij Anthos Therapeutics, Inc.
Profiel
Paris Panayiotopoulos is the founder of Anthos Therapeutics, Inc. (founded in 2018) and AvenCell Therapeutics, Inc. (founded in 2021).
He currently holds positions as Co-Chairman at FerGene, Inc., Director at European Pharmaceutical Market Research Association, Senior Managing Director at Blackstone Life Sciences Advisors LLC (since 2018), and Member at Chamber of Commerce of The United States of America.
Mr. Panayiotopoulos previously held positions as President, Chief Executive Officer & Director at ARIAD Pharmaceuticals, Inc. (2016-2017), Chairman at Genevant Sciences Corp.
(2018-2020), Director at The Medicines Co. (2017-2020), Independent Director at Corbus Pharmaceuticals Holdings, Inc. (2017-2020), Chief of Staff at Merck KGaA (2012-2013), Principal at Eli Lilly & Co. Ltd.
(1999-2004), and President at EMD Serono, Inc. (2014-2016).
Mr. Panayiotopoulos's education includes an undergraduate degree from University College London (1996) and a graduate degree from Cranfield School of Management (1997).
Actieve functies van Paris Panayiotopoulos
| Bedrijven | Functie | Begin |
|---|---|---|
| European Pharmaceutical Market Research Association | Director/Board Member | - |
Chamber of Commerce of The United States of America
 Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services The Chamber of Commerce of The United States of America provides information on how businesses can adapt their workforce development and management strategies to deal with the changing labor market. The non-profit company is based in Washington and has subsidiaries in the United States. The Chamber of Commerce of The United States of America is the world's largest business organization, advocating, connecting, informing, and fighting for business growth and success. The American company was founded by Michael Scown, and Suzanne P. Clark has been the CEO of the company since 2014. | Corporate Officer/Principal | - |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Founder | 01-01-2018 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Chairman | - |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Private Equity Investor | 01-12-2018 |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Founder | 01-10-2021 |
Eerdere bekende functies van Paris Panayiotopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Chairman | 31-07-2020 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 06-03-2020 |
| THE MEDICINES COMPANY | Director/Board Member | 31-01-2020 |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Paris Panayiotopoulos
| University College London | Undergraduate Degree |
| Cranfield School of Management | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 14 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Chamber of Commerce of The United States of America
Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services The Chamber of Commerce of The United States of America provides information on how businesses can adapt their workforce development and management strategies to deal with the changing labor market. The non-profit company is based in Washington and has subsidiaries in the United States. The Chamber of Commerce of The United States of America is the world's largest business organization, advocating, connecting, informing, and fighting for business growth and success. The American company was founded by Michael Scown, and Suzanne P. Clark has been the CEO of the company since 2014. | Commercial Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Merck Serono Co., Ltd. | |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The private company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
Blackstone Life Sciences Advisors LLC
Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
| European Pharmaceutical Market Research Association |
